Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,941 | 438 | 95.1% |
| Education | $465.49 | 7 | 4.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,396 | 155 | $0 (2024) |
| GENZYME CORPORATION | $912.40 | 26 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $908.77 | 39 | $0 (2024) |
| Janssen Biotech, Inc. | $688.66 | 21 | $0 (2024) |
| Dermavant Sciences, Inc. | $668.54 | 26 | $0 (2024) |
| Incyte Corporation | $563.31 | 28 | $0 (2024) |
| LEO Pharma Inc. | $535.87 | 20 | $0 (2024) |
| PFIZER INC. | $497.98 | 23 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $453.25 | 27 | $0 (2024) |
| Galderma Laboratories, L.P. | $373.13 | 11 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,981 | 153 | ABBVIE INC. ($550.26) |
| 2023 | $3,048 | 138 | ABBVIE INC. ($662.33) |
| 2022 | $2,384 | 112 | ABBVIE INC. ($829.14) |
| 2021 | $992.35 | 42 | AbbVie Inc. ($353.92) |
All Payment Transactions
445 individual payment records from CMS Open Payments — Page 1 of 18
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Winlevi (Drug) | Food and Beverage | In-kind items and services | $22.72 | General |
| Category: Dermatology | ||||||
| 12/19/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $20.21 | General |
| Category: IMMUNOLOGY | ||||||
| 12/17/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $2.42 | General |
| Category: IMMUNOLOGY | ||||||
| 12/16/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $20.99 | General |
| Category: Dermatology | ||||||
| 12/12/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $31.96 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/10/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $30.77 | General |
| Category: Immunology | ||||||
| 12/10/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $23.08 | General |
| Category: DERMATOLOGY | ||||||
| 12/09/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $15.06 | General |
| Category: Immunology | ||||||
| 12/05/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $118.18 | General |
| Category: DERMATOLOGY | ||||||
| 12/05/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $29.32 | General |
| Category: Immunology | ||||||
| 12/02/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $18.66 | General |
| Category: IMMUNOLOGY | ||||||
| 11/20/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $14.85 | General |
| Category: Immunology | ||||||
| 11/18/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $8.42 | General |
| Category: DERMATOLOGY | ||||||
| 11/14/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $23.43 | General |
| Category: DERMATOLOGY | ||||||
| 11/14/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $8.70 | General |
| Category: DERMATOLOGY | ||||||
| 11/14/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $4.75 | General |
| Category: IMMUNOLOGY | ||||||
| 11/12/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $5.13 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/11/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $20.84 | General |
| 11/08/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $124.98 | General |
| Category: DERMATOLOGY | ||||||
| 11/08/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $22.64 | General |
| Category: DERMATOLOGY | ||||||
| 11/06/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $30.36 | General |
| Category: DERMATOLOGY | ||||||
| 11/04/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $18.17 | General |
| Category: Immunology | ||||||
| 10/30/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $24.11 | General |
| Category: Immunology | ||||||
| 10/25/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $1.23 | General |
| Category: IMMUNOLOGY | ||||||
| 10/21/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $20.61 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 1,617 | 2,787 | $318,478 | $88,182 |
| 2022 | 16 | 1,702 | 2,958 | $334,386 | $89,722 |
| 2021 | 15 | 1,436 | 2,420 | $268,025 | $75,904 |
| 2020 | 11 | 965 | 1,598 | $153,203 | $40,815 |
All Medicare Procedures & Services
57 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 438 | 538 | $97,311 | $26,946 | 27.7% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 203 | 225 | $46,382 | $13,290 | 28.7% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 306 | 378 | $51,216 | $12,136 | 23.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 92 | 121 | $31,014 | $8,255 | 26.6% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 92 | 103 | $23,729 | $7,180 | 30.3% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 222 | 1,126 | $15,118 | $4,704 | 31.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 92 | 106 | $12,041 | $3,327 | 27.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 50 | 50 | $11,267 | $2,728 | 24.2% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 24 | 26 | $9,429 | $2,723 | 28.9% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 18 | 22 | $7,386 | $2,563 | 34.7% |
| 17272 | Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm | Office | 2023 | 12 | 12 | $4,590 | $1,438 | 31.3% |
| 10060 | Simple or single drainage of skin abscess | Office | 2023 | 13 | 13 | $3,272 | $1,067 | 32.6% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 29 | 34 | $3,471 | $1,025 | 29.5% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 15 | 15 | $2,145 | $694.01 | 32.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 11 | 18 | $108.00 | $105.84 | 98.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 443 | 550 | $100,793 | $27,720 | 27.5% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 220 | 263 | $55,314 | $14,767 | 26.7% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 303 | 395 | $54,147 | $12,385 | 22.9% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 83 | 99 | $23,004 | $6,803 | 29.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 73 | 92 | $23,784 | $6,778 | 28.5% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 232 | 1,175 | $16,239 | $4,764 | 29.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 73 | 73 | $16,524 | $4,211 | 25.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 107 | 119 | $13,602 | $3,906 | 28.7% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2022 | 24 | 24 | $8,765 | $2,857 | 32.6% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2022 | 23 | 25 | $8,620 | $2,031 | 23.6% |
About Sara Barr, PA
Sara Barr, PA is a Medical healthcare provider based in Duluth, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/16/2007. The National Provider Identifier (NPI) number assigned to this provider is 1801930862.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Sara Barr, PA has received a total of $9,406 in payments from pharmaceutical and medical device companies, with $2,981 received in 2024. These payments were reported across 445 transactions from 20 companies. The most common payment nature is "Food and Beverage" ($8,941).
As a Medicare-enrolled provider, Barr has provided services to 5,720 Medicare beneficiaries, totaling 9,763 services with total Medicare billing of $294,623. Data is available for 4 years (2020–2023), covering 57 distinct procedure/service records.
Practice Information
- Specialty Medical
- Location Duluth, GA
- Active Since 02/16/2007
- Last Updated 03/26/2014
- Taxonomy Code 363AM0700X
- Entity Type Individual
- NPI Number 1801930862
Products in Payments
- DUPIXENT (Biological) $1,664
- RINVOQ (Biological) $1,324
- SKYRIZI (Biological) $778.75
- TREMFYA (Drug) $677.14
- VTAMA (Drug) $668.54
- OPZELURA (Drug) $563.31
- ADBRY (Biological) $535.87
- Sotyktu (Drug) $453.25
- EUCRISA (Drug) $372.02
- AKLIEF (Drug) $189.24
- TALTZ (Drug) $171.89
- COSENTYX (Biological) $149.09
- LIBTAYO (Biological) $144.08
- CIBINQO (Drug) $125.96
- Bimzelx (Biological) $120.50
- ILUMYA (Biological) $106.50
- EPSOLAY (Drug) $92.33
- Winlevi (Drug) $90.06
- SILIQ (Drug) $56.85
- HUMIRA (Biological) $53.44
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Medical Doctors in Duluth
Mrs. Nathina Melton, Pa-C, PA-C
Medical — Payments: $8,236
Leah Umbehant, Pa-C, PA-C
Medical — Payments: $6,163
Jasmine Joseph, Pa, PA
Medical — Payments: $2,190
Nicole Stepan, Pa-C, PA-C
Medical — Payments: $737.51
Henry Heard, Pa, PA
Medical — Payments: $169.85
Arlene Salmon, Pa, PA
Medical — Payments: $124.17